Faculty Opinions recommendation of Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.

2010 ◽  
Author(s):  
Hugues Abriel ◽  
Jean-Sébastien Rougier
Keyword(s):  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Long Qt ◽  
Specific Therapy ◽  
Qt Syndrome ◽  
Trafficking Defects ◽  
Type 3 ◽  
Scn5a Mutation

scholarly journals Trafficking Defects and Gating Abnormalities of a Novel SCN5A Mutation Question Gene-Specific Therapy in Long QT Syndrome Type 3

2010 ◽  
Vol 106 (8) ◽  
pp. 1374-1383 ◽  
Author(s):  
Yanfei Ruan ◽  
Marco Denegri ◽  
Nian Liu ◽  
Tiziana Bachetti ◽  
Morena Seregni ◽  
...  
Keyword(s):  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Long Qt ◽  
Specific Therapy ◽  
Qt Syndrome ◽  
Trafficking Defects ◽  
Type 3 ◽  
Scn5a Mutation

scholarly journals Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3

2016 ◽  
Vol 67 (9) ◽  
pp. 1053-1058 ◽  
Author(s):  
Andrea Mazzanti ◽  
Riccardo Maragna ◽  
Alessandro Faragli ◽  
Nicola Monteforte ◽  
Raffaella Bloise ◽  
...  
Keyword(s):  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Long Qt ◽  
Specific Therapy ◽  
Qt Syndrome ◽  
Type 3

Diagnosis of epilepsy using an implantable loop recorder in a child with long-QT syndrome type 3

2013 ◽  
Vol 55 (2) ◽  
pp. 251-253 ◽  
Author(s):  
Kazuhiro Takahashi ◽  
Akira Miyake ◽  
Yoshimitsu Otsuka ◽  
Masaharu Ohfu ◽  
Hitoshi Ganaha
Keyword(s):  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Implantable Loop Recorder ◽  
Long Qt ◽  
Loop Recorder ◽  
Qt Syndrome ◽  
Type 3

scholarly journals Effects of Flecainide in Patients With New SCN5A Mutation : Mutation-Specific Therapy for Long-QT Syndrome?

Circulation ◽  
2000 ◽  
Vol 101 (14) ◽  
pp. 1698-1706 ◽  
Author(s):  
J. Benhorin ◽  
R. Taub ◽  
M. Goldmit ◽  
B. Kerem ◽  
R. S. Kass ◽  
...  
Keyword(s):  
Long Qt Syndrome ◽  
Long Qt ◽  
Specific Therapy ◽  
Qt Syndrome ◽  
Scn5a Mutation

scholarly journals Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3

2017 ◽  
Vol 3 (1) ◽  
pp. 104-108 ◽  
Author(s):  
Reina Bianca Tan ◽  
Sujata Chakravarti ◽  
Melissa Busovsky-McNeal ◽  
Abigail Walsh ◽  
Frank Cecchin
Keyword(s):  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Long Qt ◽  
Qt Syndrome ◽  
Type 3

scholarly journals The citrus flavanone hesperetin preferentially inhibits slow‐inactivating currents of a long QT syndrome type 3 syndrome Na + channel mutation

2019 ◽  
Vol 176 (8) ◽  
pp. 1090-1105 ◽  
Author(s):  
Julio Alvarez‐Collazo ◽  
Alejandro López‐Requena ◽  
Loipa Galán ◽  
Ariel Talavera ◽  
Julio L. Alvarez ◽  
...  
Keyword(s):  
Long Qt Syndrome ◽  
Na Channel ◽  
Syndrome Type ◽  
Long Qt ◽  
Channel Mutation ◽  
Qt Syndrome ◽  
Type 3

scholarly journals Ventricular dysfunction in a family with long QT syndrome type 3

EP Europace ◽  
2013 ◽  
Vol 15 (10) ◽  
pp. 1516-1521 ◽  
Author(s):  
Yoran M. Hummel ◽  
Arthur A.M. Wilde ◽  
Adriaan A. Voors ◽  
Silvia Bugatti ◽  
Hans L. Hillege ◽  
...  
Keyword(s):  
Long Qt Syndrome ◽  
Ventricular Dysfunction ◽  
Syndrome Type ◽  
Long Qt ◽  
Qt Syndrome ◽  
Type 3

Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker

2014 ◽  
Vol 171 (1) ◽  
pp. 90-92 ◽  
Author(s):  
Maarten P. van den Berg ◽  
Freek van den Heuvel ◽  
J. Peter van Tintelen ◽  
Paul G.A. Volders ◽  
Isabelle C. van Gelder
Keyword(s):  
Successful Treatment ◽  
Beta Blocker ◽  
Long Qt Syndrome ◽  
Syndrome Type ◽  
Long Qt ◽  
Qt Syndrome ◽  
Type 3
Sign in / Sign up

Export Citation Format

Share Document